FDA Inspection 1311208 — Pim Mutsaers, MD
The FDA completed an inspection of Pim Mutsaers, MD on March 20, 2026 in Rotterdam. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 20, 2026
- Fiscal Year
- 2026
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Rotterdam (Netherlands)
Additional Details
Clinical Investigator (CI)